A detailed history of Virtus ETF Advisers LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,747 shares of CYTK stock, worth $83,279. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,747
Previous 1,717 1.75%
Holding current value
$83,279
Previous $93,000 1.08%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $1,536 - $1,804
30 Added 1.75%
1,747 $92,000
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $31,109 - $48,782
-650 Reduced 27.46%
1,717 $93,000
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $10,327 - $17,505
-162 Reduced 6.41%
2,367 $165,000
Q4 2023

Feb 15, 2024

SELL
$26.88 - $83.49 $7,929 - $24,629
-295 Reduced 10.45%
2,529 $211,000
Q3 2023

Nov 07, 2023

SELL
$29.46 - $36.61 $8,307 - $10,324
-282 Reduced 9.08%
2,824 $83,000
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $21,561 - $26,935
661 Added 27.03%
3,106 $101,000
Q1 2023

May 15, 2023

SELL
$33.36 - $45.71 $31,291 - $42,875
-938 Reduced 27.73%
2,445 $86,000
Q4 2022

Feb 14, 2023

BUY
$35.77 - $51.11 $25,682 - $36,696
718 Added 26.94%
3,383 $155,000
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $693 - $981
18 Added 0.68%
2,665 $129,000
Q2 2022

Aug 12, 2022

SELL
$33.93 - $48.92 $51,878 - $74,798
-1,529 Reduced 36.61%
2,647 $104,000
Q1 2022

May 16, 2022

SELL
$29.74 - $46.0 $7,405 - $11,454
-249 Reduced 5.63%
4,176 $154,000
Q4 2021

Feb 14, 2022

SELL
$34.35 - $46.38 $181,986 - $245,721
-5,298 Reduced 54.49%
4,425 $202,000
Q3 2021

Nov 15, 2021

SELL
$18.54 - $35.74 $9,529 - $18,370
-514 Reduced 5.02%
9,723 $348,000
Q2 2021

Aug 10, 2021

SELL
$19.79 - $26.99 $77,161 - $105,234
-3,899 Reduced 27.58%
10,237 $203,000
Q1 2021

May 17, 2021

BUY
$18.57 - $25.68 $4,586 - $6,342
247 Added 1.78%
14,136 $329,000
Q4 2020

Feb 12, 2021

SELL
$15.26 - $28.61 $8,057 - $15,106
-528 Reduced 3.66%
13,889 $289,000
Q3 2020

Nov 13, 2020

SELL
$20.58 - $28.96 $40,563 - $57,080
-1,971 Reduced 12.03%
14,417 $312,000
Q2 2020

Aug 05, 2020

SELL
$11.15 - $24.64 $193,630 - $427,898
-17,366 Reduced 51.45%
16,388 $386,000
Q1 2020

May 14, 2020

SELL
$8.75 - $16.3 $43,155 - $80,391
-4,932 Reduced 12.75%
33,754 $398,000
Q4 2019

Feb 13, 2020

BUY
$7.95 - $11.84 $96,982 - $144,436
12,199 Added 46.06%
38,686 $410,000
Q3 2019

Nov 12, 2019

SELL
$10.82 - $14.25 $15,959 - $21,018
-1,475 Reduced 5.28%
26,487 $301,000
Q2 2019

Aug 13, 2019

SELL
$7.95 - $11.25 $46,078 - $65,205
-5,796 Reduced 17.17%
27,962 $315,000
Q1 2019

May 14, 2019

SELL
$5.95 - $10.19 $22,187 - $37,998
-3,729 Reduced 9.95%
33,758 $273,000
Q4 2018

Feb 05, 2019

SELL
$5.91 - $9.29 $74,406 - $116,961
-12,590 Reduced 25.14%
37,487 $237,000
Q3 2018

Nov 14, 2018

SELL
$6.4 - $9.85 $229,139 - $352,659
-35,803 Reduced 41.69%
50,077 $493,000
Q2 2018

Aug 10, 2018

SELL
$6.9 - $9.9 $51,260 - $73,547
-7,429 Reduced 7.96%
85,880 $713,000
Q1 2018

May 14, 2018

BUY
$7.2 - $10.05 $364,780 - $509,173
50,664 Added 118.8%
93,309 $672,000
Q4 2017

Feb 14, 2018

BUY
$7.25 - $15.65 $139,562 - $301,262
19,250 Added 82.28%
42,645 $348,000
Q3 2017

Nov 14, 2017

BUY
$12.0 - $15.0 $25,680 - $32,100
2,140 Added 10.07%
23,395 $339,000
Q2 2017

Aug 14, 2017

BUY
N/A
21,255
21,255 $257,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.49B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.